Except for points 4 and 7 of what "…7 things every reporter should know," I think it isn't a bad list. The questions to ask nanotech companies appears to me to be a pretty standard set of "due dilgence" questions an investor should ask – and therefore something a reporter should ask (at a minimum).

The use of many reasonable points and the references to a "PhD", among other things, appears to be a deliberate use of what Cialdini ("Influence: The Psychology of Persuasion") calls the authority principle to legitimize the couple of unreasonable ones.

Here is the direct click URL. Bear in mind when reading that the author is Dr. Nathan Tinker.

Dr. Tinker's PhD is in 17th century English literature from Fordham University (ref). Dr. Tinker is also the Executive Vice President of the NanoBusiness Alliance and the Executive Director of the Sabin Vaccine Institute Cancer Vaccine Consortium (ref).

Though the paper indicates he has a reasonable understanding of nanotechnology, as Christine indicates there are problems when it comes down to the details. The article cites him as a "Senior Director, The Nanotech Company", yet I cannot find mention of him on their web site. It begs questions such as whether The Nanotech Company is simply collecting names or references and whether Dr. Tinker is catering to that demand?

http://unspun.mithuro.com/content/view/48/33/